These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 15553105

  • 1. Clinical study of the therapeutic efficacy and safety of emedastine difumarate versus terfenadine in the treatment of seasonal allergic rhinitis.
    Corrado ME, Radicioni MM, Hartwig J, Assandri A, Oldeman HG, Mion A.
    Arzneimittelforschung; 2004; 54(10):660-5. PubMed ID: 15553105
    [Abstract] [Full Text] [Related]

  • 2. Clinical study of the therapeutic efficacy and safety of emedastine difumarate versus cetirizine in the treatment of seasonal allergic rhinitis.
    Horak F, Stübner P, Zieglmayer R, Kavina A, Corrado ME, Assandri A, Mion A.
    Arzneimittelforschung; 2004; 54(10):666-72. PubMed ID: 15553106
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.
    Meltzer EO, Scheinmann P, Rosado Pinto JE, Bachert C, Hedlin G, Wahn U, Finn AF, Ruuth E.
    Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959
    [Abstract] [Full Text] [Related]

  • 4. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis.
    Lockey RF, Widlitz MD, Mitchell DQ, Lumry W, Dockhorn R, Woehler T, Grossman J.
    Ann Allergy Asthma Immunol; 1996 May; 76(5):448-54. PubMed ID: 8630719
    [Abstract] [Full Text] [Related]

  • 5. The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms.
    Stokes JR, Romero FA, Allan RJ, Phillips PG, Hackman F, Misfeldt J, Casale TB.
    J Allergy Clin Immunol; 2012 Feb; 129(2):409-12, 412.e1-2. PubMed ID: 22196768
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of intranasally applied dimetindene maleate solution versus placebo in the treatment of seasonal allergic rhinitis.
    Horak F, Unkauf M, Beckers C, Mittermaier EM.
    Arzneimittelforschung; 2000 Dec; 50(12):1099-105. PubMed ID: 11190775
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of the emedastine patch, a novel transdermal drug delivery system for allergic rhinitis: Phase III, multicenter, randomized, double-blinded, placebo-controlled, parallel-group comparative study in patients with seasonal allergic rhinitis.
    Okubo K, Uchida E, Terahara T, Akiyama K, Kobayashi S, Tanaka Y.
    Allergol Int; 2018 Jul; 67(3):371-379. PubMed ID: 29395965
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of intranasally applied dimetindene maleate solution. Multicenter study in children under 14 years suffering from seasonal allergic rhinitis.
    Bauer CP, Unkauf M.
    Arzneimittelforschung; 2001 Jul; 51(3):232-7. PubMed ID: 11304939
    [Abstract] [Full Text] [Related]

  • 9. Brompheniramine, terfenadine, and placebo in allergic rhinitis.
    Klein GL, Littlejohn T, Lockhart EA, Furey SA.
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):365-70. PubMed ID: 8933774
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders.
    Prenner BM, Capano D, Harris AG.
    Clin Ther; 2000 Jun; 22(6):760-9. PubMed ID: 10929922
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis.
    Bernstein DI, Schoenwetter WF, Nathan RA, Storms W, Ahlbrandt R, Mason J.
    Ann Allergy Asthma Immunol; 1997 Nov; 79(5):443-8. PubMed ID: 9396979
    [Abstract] [Full Text] [Related]

  • 12. Emedastine difumarate versus loratadine in chronic idiopathic urticaria: a randomized, double-blind, controlled European multicentre clinical trial.
    Pons-Guiraud A, Nekam K, Lahovsky J, Costa A, Piacentini A.
    Eur J Dermatol; 2006 Nov; 16(6):649-54. PubMed ID: 17229605
    [Abstract] [Full Text] [Related]

  • 13. Triamcinolone acetonide aqueous nasal spray versus loratadine in seasonal allergic rhinitis: efficacy and quality of life.
    Condemi J, Schulz R, Lim J.
    Ann Allergy Asthma Immunol; 2000 May; 84(5):533-8. PubMed ID: 10831008
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
    LaForce CF, Corren J, Wheeler WJ, Berger WE, Rhinitis Study Group.
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
    [Abstract] [Full Text] [Related]

  • 15. Emedastine difumarate: a review of its potential ameliorating effect for tissue remodeling in allergic diseases.
    Murota H, Katayama I.
    Expert Opin Pharmacother; 2009 Aug; 10(11):1859-67. PubMed ID: 19558341
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen.
    Jacobs R, Martin B, Hampel F, Toler W, Ellsworth A, Philpot E.
    Curr Med Res Opin; 2009 Jun; 25(6):1393-401. PubMed ID: 19419338
    [Abstract] [Full Text] [Related]

  • 17. An open label, active controlled, multicentric clinical trial to assess the efficacy and safety of fluticasone furoate nasal spray in adult Indian patients suffering from allergic rhinitis.
    Kubavat AH, Pawar P, Mittal R, Sinha V, Shah UB, Ojha T, Khippal N, Patel T.
    J Assoc Physicians India; 2011 Jul; 59():424-8. PubMed ID: 22315746
    [Abstract] [Full Text] [Related]

  • 18. Brompheniramine maleate: a double-blind, placebo-controlled comparison with terfenadine for symptoms of allergic rhinitis.
    Thoden WR, Druce HM, Furey SA, Lockhart EA, Ratner P, Hampel FC, van Bavel J.
    Am J Rhinol; 1998 Jul; 12(4):293-9. PubMed ID: 9740926
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
    Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM.
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
    Kuna P, Bachert C, Nowacki Z, van Cauwenberge P, Agache I, Fouquert L, Roger A, Sologuren A, Valiente R, Bilastine International Working Group.
    Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.